ACTA STInG in collaboration with Cytel, invite you to come on a whirlwind tour of the current and developing statistical guidelines for clinical trials, all distilled into seven steps. This is an opportunity to be introduced, refreshed or updated on the statistical aspects of GCP in two 1 hour seminars. ICH-GCP guidelines are used in clinical trials around the globe with the main aim of protecting and preserving human rights, which is relevant for both investigator-led and industry sponsored trials. They are an international ethical and scientific quality standard; for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials.
STEPS 1-5: Understanding key statistical principles in ICH E9 (Statistical Principles for Clinical Trials, R1 Estimands & sensitivity analyses), ICH E10 (Choice of Control Group in Clinical Trials), ICH E6 (Good Clinical Practice), E17 (Multi-Regional Clinical Trials).
Target Audience: Statisticians
Presenter: James Matcham
The seminars will be delivered by James Matcham, who has over 30 years’ experience as a statistician in the pharmaceutical industry. He has led the development of early clinical trial design, decisions and analysis and the development of regulatory/reimbursement approvals for biotechnology products, involving company representation at regulatory submissions in the US and EU.
James has been a member of the society for Pharmaceutical Statistics (PSI) for over 30 years, serving on the Scientific and Training Committees, as well as the Board of Directors. He has also served on the Professional Affairs Committee of the Royal Statistical Society (RSS), where he has been a Chartered Statistician for over 25 years, and is currently a member of the Scientific Committee of the European Federation of Pharmaceutical Statistics. In 2020, James moved to the Strategic Consulting group in Cytel.
Data and Safety Monitoring Boards Webinar Series: How to plan well and be prepared for the unexpected
Statistical Analysis Plan
What are the benefits of adaptive designs?
How do adaptive trial sizes work?
What is an adaptive clinical trial?
What is response adaptive randomisation?
Data Safety and Monitoring Boards (DSMB) for Adaptive Trials Webinar video
Data Safety and Monitoring Boards (DSMB) for Adaptive Trials Webinar slides
ACTA Trial of the Year Award 2020 guidelines and nomination forms
Bayesian adaptive randomised clinical trials flyer
ACTA STInG grant advice for trial statisticians
ACTA STInG Notes from Members’ meeting, October 2019
Adaptive Design Clinical Trials
Hackathon of Novel Trial Designs part two
Hackathon of Novel Trial Designs part one
Studies Within A Trial SWATs webinar
Innovative Trial Design and Conduct Reference Group Objectives and Directions
ACTA STInG 2017 Member Survey Results
Novel approaches to healthcare effectiveness research outside Australia
ACTA STInG Submission to the NHMRC Structural Review
Statistical principles – Data and Safety Monitoring Boards Webinar Series
How to plan well and be prepared for the unexpected – Data and Safety Monitoring Boards Webinar Series
Webinar: Data Safety and Monitoring Boards for Adaptive Trials
Bayesian Adaptive Randomised Clinical Trials Workshop, Sydney
Bayesian Adaptive Randomised Clinical Trials Workshop, Melbourne
Bayesian Adaptive Trials Workshops: Perth
Workshop: Pragmatic randomised trial designs for evaluating health policy and practice change interventions